Breast Fat Grafting
别名: 自体脂肪移植丰胸, 无假体隆胸, 脂肪填充丰胸, 脂肪移植隆胸, 自体脂肪丰胸, 自体脂肪隆胸, fat transfer breast augmentation, 自体脂肪移植
Breast fat grafting (fat transfer breast augmentation) uses the patient's own liposuctioned fat to modestly enlarge or reshape the breast without an implant.
What is breast fat grafting?
Breast fat grafting, or fat transfer breast augmentation, enlarges or reshapes the breast using fat taken from the patient's own body by liposuction. The fat is processed and injected into the breast in small amounts. It gives a modest, natural increase without an implant, but part of the graft is resorbed, so more than one session may be needed.
关键事实
| 属性 | 值 | 来源 |
|---|---|---|
| Definition | Fat is taken by liposuction from other parts of the body and injected to enlarge the breasts | [2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons |
| Typical donor sites | Usually the abdomen or flanks, though fat can be taken from almost anywhere (surgeon quoted by ASPS)截至 2024年11月18日 | [3]organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons |
| Typical size increase | Surgeon quoted by ASPS: ideal candidate wants half a cup to one cup; a larger increase may take two to three procedures cup size截至 2024年11月18日 | [3]organizationFat transfer for breast augmentation: The ins and outs of this implant alternativeAmerican Society of Plastic Surgeons |
| Listed risks | Cysts, infection, microcalcification, death of fat cells (necrosis), and some transferred fat leaving the breast area | [2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons |
| Pre-expansion option | Surgeons may recommend an external tissue expansion system in the weeks before surgery | [2]organizationFat Transfer Breast Augmentation Risks and SafetyAmerican Society of Plastic Surgeons |
| Pooled volume retention | 54% (95% CI 48.5–59.5%) across 25 studies, follow-up 3–36 months percent截至 2024年2月1日 | [4]journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) |
| Retention by fat preparation method | Centrifugation 51.5% vs sedimentation 38.7% pooled retention percent截至 2024年2月1日 | [4]journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract recordJournal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) |
| Oncologic safety evidence | Meta-analysis of 15 studies (8,541 participants): no difference in overall survival, disease-free survival or local recurrence between patients who had fat grafting after breast cancer surgery and controls截至 2022年4月1日 | [5]journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract recordBMC Cancer (via Europe PMC) |
| 1987 professional position | ASPRS (predecessor of ASPS) condemned autologous fat injection for breast augmentation over concerns about cancer detection | [6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central |
| 2009 ASPS Fat Graft Task Force | Concluded that the literature then available showed no association between fat grafting and higher rates of malignancy | [6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central |
| US regulatory status | Following FDA guidance issued in November 2017, autologous fat grafts do not require premarket approval; stromal vascular fraction products receive closer review截至 2017年11月1日 | [6]journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64)Seminars in Plastic Surgery (Thieme) via PubMed Central |
| Relevant FDA guidance | Same Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception截至 2017年11月1日 | [7]governmentSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the ExceptionUS Food and Drug Administration (CBER) |
| Suitable for | People wanting a relatively small increase in breast size who have enough donor fat (ASPS) | [1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons |
| Sessions | More than one session may be needed because part of the graft is resorbed | [1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons |
| Imaging note | Fat necrosis, cysts and calcifications can appear on mammograms and must be interpreted by a radiologist | [1]organizationFat Transfer Breast AugmentationAmerican Society of Plastic Surgeons |
概述
Breast fat grafting (fat transfer breast augmentation) is a surgical procedure that uses liposuction to take a patient's own fat, usually from the abdomen or flanks, and inject it into the breasts after processing. It is used for small cosmetic augmentations and alongside breast reconstruction. Only part of the injected fat survives. A 2024 meta-analysis of 25 studies found that about 54% of the grafted volume remained, with results varying by how the fat was prepared. Reported risks include fat necrosis, cysts, microcalcifications and infection. A meta-analysis of breast cancer patients found no difference in survival or local recurrence between those who had fat grafting and those who did not. In the US, fat removed and reinjected in the same operation can qualify for an FDA same-surgical-procedure exception. Readers should check the surgeon's training, how much volume to expect and what breast imaging follow-up is planned.
已验证服务机构
付费展示均有标注。验证与付费无关。SC301의원
SC301의원 (SC301 Clinic) is a plastic surgery clinic in Gangnam, Seoul, South Korea whose official site presents SVF (stromal vascular fraction) fat grafting for the breast and face, liposuction, lifting and cell banking as its main services.
查看机构证据与声明
官方声明是服务方的陈述,除非另有标注,否则未经 worldwiki 验证。| 主张 | 类型 | 证据 | 来源 |
|---|---|---|---|
| Fat transfer breast augmentation produces a relatively small size increase and may need repeat sessions. | outcome | 有限 | Fat Transfer Breast Augmentation |
参考来源
独立来源比例 90% (18/20) · 提供方撰写 2- 等级 C · organizationFat Transfer Breast Augmentation — American Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
- 等级 C · organizationFat Transfer Breast Augmentation Risks and Safety — American Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
- 等级 C · organizationFat transfer for breast augmentation: The ins and outs of this implant alternative — American Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
- 等级 B · journalVolume retention rate after breast autogenous fat grafting and related influencing factors: A systematic review and meta-analysis (Hu S, Xu H; PMID 38160589; DOI 10.1016/j.bjps.2023.12.003) – abstract record — Journal of Plastic, Reconstructive & Aesthetic Surgery (via Europe PMC) · 访问于 2026年9月20日 · 证据页
- 等级 B · journalThe oncological safety of autologous fat grafting: a systematic review and meta-analysis (Goncalves R et al.; BMC Cancer; PMCID PMC9004160) – abstract record — BMC Cancer (via Europe PMC) · 访问于 2026年9月20日 · 证据页
- 等级 B · journalSafety and Regulation of Fat Grafting (Raj S, Abu-Ghname A, Davis MJ, Izaddoost SA, Winocour SJ; Semin Plast Surg 2020;34(1):59–64) — Seminars in Plastic Surgery (Thieme) via PubMed Central · 访问于 2026年9月20日 · 证据页
- 等级 A · governmentSame Surgical Procedure Exception under 21 CFR 1271.15(b): Questions and Answers Regarding the Scope of the Exception — US Food and Drug Administration (CBER) · 访问于 2026年9月19日 · 证据页
- 等级 A · governmentBreast enlargement (implants) — NHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页
- 等级 C · organizationBreast Augmentation — American Society of Plastic Surgeons · 访问于 2026年9月20日 · 证据页
- 等级 B · academicAdvancing fat graft survival: from adipose-derived stem cell mechanisms to next-generation regenerative strategies — Frontiers in Cell and Developmental Biology (2026) · 访问于 2026年9月20日 · 证据页
- 等级 B · academic提供方撰写A Study on Breast Augmentation Using Fat Grafting With Stromal Vascular Fraction (Shin DJ, Ann Plast Surg 2023;90(4):380-384) — Annals of Plastic Surgery · 访问于 2026年9月20日 · 证据页
- 等级 B · academicImpact of donor site on fat graft survival in autologous fat transfer to the breast: A systematic review — JPRAS Open (2026) · 访问于 2026年9月20日 · 证据页
- 等级 B · academicCell-Assisted Lipotransfer: A Systematic Review of its Efficacy — Aesthetic Plastic Surgery (2024) · 访问于 2026年9月20日 · 证据页
- 等级 B · academicComparison of the Efficacy and Safety of Cell-Assisted Lipotransfer and Platelet-Rich Plasma Assisted Lipotransfer — Cell Transplantation (2021) · 访问于 2026年9月20日 · 证据页
- 等级 B · academicSafety profile of autologous adipose-derived stromal vascular fraction in clinical use: an exhaustive literature review — Stem Cell Research & Therapy (2026) · 访问于 2026年9月20日 · 证据页
- 等级 B · academic提供方撰写Breast Augmentation by Fat Transplantation With Adipose-Derived Stem/Stromal Cells (Shin DJ, Aesthet Surg J Open Forum 2020) — Aesthetic Surgery Journal Open Forum · 访问于 2026年9月20日 · 证据页
- 等级 A · governmentFDA Warns About Stem Cell Therapies — U.S. Food and Drug Administration · 访问于 2026年9月15日 · 证据页
- 等级 C · organization지방이식 (Fat transplantation) — N의학정보 — 서울대학교병원 · 访问于 2026年9月19日 · 证据页
- 等级 A · governmentLiposuction — NHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页
- 等级 A · governmentSurgical fat transfer (lipofilling) — NHS (UK National Health Service) · 访问于 2026年9月20日 · 证据页